ZBH vs. GEHC, PHG, SOLV, SNN, PEN, GKOS, STVN, BLCO, INSP, and NARI
Should you be buying Zimmer Biomet stock or one of its competitors? The main competitors of Zimmer Biomet include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry.
Zimmer Biomet vs.
GE HealthCare Technologies (NASDAQ:GEHC) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk.
GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. Zimmer Biomet is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.
Zimmer Biomet has a net margin of 14.27% compared to GE HealthCare Technologies' net margin of 8.56%. GE HealthCare Technologies' return on equity of 25.19% beat Zimmer Biomet's return on equity.
GE HealthCare Technologies has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.
Zimmer Biomet received 878 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 67.16% of users gave Zimmer Biomet an outperform vote while only 57.89% of users gave GE HealthCare Technologies an outperform vote.
GE HealthCare Technologies pays an annual dividend of $0.12 per share and has a dividend yield of 0.1%. Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Zimmer Biomet pays out 18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
In the previous week, Zimmer Biomet had 1 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 13 mentions for Zimmer Biomet and 12 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.15 beat Zimmer Biomet's score of 0.85 indicating that GE HealthCare Technologies is being referred to more favorably in the media.
GE HealthCare Technologies currently has a consensus price target of $96.00, indicating a potential upside of 13.29%. Zimmer Biomet has a consensus price target of $123.33, indicating a potential upside of 12.47%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.
82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by company insiders. Comparatively, 0.7% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
GE HealthCare Technologies beats Zimmer Biomet on 11 of the 21 factors compared between the two stocks.
Get Zimmer Biomet News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Zimmer Biomet Competitors List
Related Companies and Tools
This page (NYSE:ZBH) was last updated on 1/18/2025 by MarketBeat.com Staff